Evolut™ FX+ System for transcatheter aortic valve replacement (TAVR)
The Evolut™ FX+ transcatheter aortic valve system is designed with specific features intended to enable lifetime management solutions such as coronary access.
Download specifications
Overview
Explore the Evolut™ FX+ system.
Built on the original CoreValveTM platform, the Evolut™ FX+ valve is engineered with specific design elements to enable coronary access and promote sustained valve performance over time.1
Performance as compared to Evolut™ PRO+ and FX system in bench testing. Bench testing may not be indicative of clinical performance.
TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.
Product details
Access
Designed with three windows that are 4 times larger to enable lifetime management solutions such as coronary access.2
Without compromise
Designed to maintain the same radial force at the inflow and structural strength at the outflow as the Evolut™ FX valve.1
Performance as compared to Evolut™ PRO+ and FX system in bench testing. Bench testing may not be indicative of clinical performance.
Manuals and technical guides
Access instructions for use and other technical manuals in the Medtronic Manual Library. Search by the product name (e.g., Evolut™) or model number. You may also call 800-961-9055 for a copy of the manual.
Resources
Find details on the Evolut™ FX+ system.
Get support.
Reach out to LifeLine CardioVascular Tech Support with questions.
877-526-7890
Education and resources
Find more details TAVR information, educational resources, and tools.
Evolut™ TAVR in action
Explore our valve design and the performance of the Evolut™ platform over time.
1. Based on Evolut™ FX+ Test Reports: D01073856, D01095344, D01084996. Medtronic data on file. Performance as compared to Evolut™ PRO+ and FX system in bench testing. Bench testing may not be indicative of clinical performance.
2. Based on Evolut™ FX+ Test Report: DO1106198 Rev. A. Medtronic computational data model on file compared to the Evolut™ platform. Bench top computational model may not be indicative of clinical performance.